secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2026-07-30T20:09:48+00:00
Accession:  0000310764-26-000048
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q2 2026: net sales $6.6B (+9.4%), adj EPS $3.69 (+17.9%), narrows FY guidance
--------------------------------------------------------------------------------

- Q2 net sales $6.6B, up 9.4% reported and 9.0% organic; MedSurg/Neuro +9.2% organic, Orthopaedics +8.6%.
- Reported EPS $3.30 (+44.1%), adjusted EPS $3.69 (+17.9%); adjusted operating margin 27.4% (+170 bps).
- FY 2026 guidance narrowed: organic sales growth 8.3%-9.3%, adjusted EPS $14.95-$15.10.
- CEO cites recovery from cyber incident and strong execution; momentum regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076426000048/0000310764-26-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076426000048/syk-20260730.htm
  HTML page:      https://secwatch.observer/filing/0000310764-26-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer